Search

Your search keyword '"María Guirado-Risueño"' showing total 3 results
Start Over Author "María Guirado-Risueño" Topic lung cancer
3 results on '"María Guirado-Risueño"'

1. Representatividad del Registro de Tumores Torácicos de España. Comparación de datos sociodemográficos con otros registros nacionales

Author

Cristina Candal-Pedreira, Alberto Ruano-Ravina, Enric Carcereny, Delvys Rodríguez-Abreu, María Guirado-Risueño, Rafael López-Castro, Bartomeu Massutí, Ana Blasco, Ana Laura Ortega, and Mariano Provencio

Subjects
Lung cancer, Spain, Cancer registry, Sex, Age, Public aspects of medicine, RA1-1270
Abstract

Resumen: Objetivo: En España, debido a la falta de datos, se creó un registro de cáncer de pulmón, el Registro de Tumores Torácicos (RTT), el cual debería demostrar su comparabilidad con los datos poblacionales para tener una representatividad adecuada. Con esta finalidad, se comparan las características sociodemográficas del RTT con los datos de incidencia de la Red de Registros de Cáncer (REDECAN) y de mortalidad del Instituto Nacional de Estadística (INE). Método: Se utilizaron las fuentes de datos de cáncer de pulmón disponibles hasta el momento: REDECAN e INE. De cada fuente se recogieron los casos de cáncer de pulmón globales y desagregados por sexo y por grupos de edad, y se compararon los datos para el periodo 2017-2020. Se calcularon las proporciones por sexo y grupo de edad del RTT respecto a ambas bases de datos (que recogen incidencia y mortalidad), para el periodo completo de estudio y desglosado por año. Resultados: Se incluyeron 17.109 casos incidentes de cáncer de pulmón incluidos en el RTT, 58.668 casos incidentes estimados de REDECAN y 88.083 muertes entre 2017 y 2020 del INE. En cuanto al sexo, las proporciones son muy similares entre las tres fuentes y las diferencias no superan el 4%. En cuanto a la edad, las diferencias no son elevadas, siendo mayores para los datos de mortalidad en el grupo de mayor edad del INE frente al RTT. Conclusiones: El RTT parece ser representativo de los casos de cáncer de pulmón diagnosticados en España para los años 2019 y 2020, tanto por sexo como por edad. Esto permite poder caracterizar con exactitud el estado de esta enfermedad, primera causa de muerte por cáncer en España, y que el análisis de resultados que se vayan a obtener del RTT pueda ser aplicado a los casos de cáncer de pulmón diagnosticados en nuestro país. Abstract: Objective: In Spain, due to the lack of data at national level a lung cancer registry, the Thoracic Tumour Registry (TTR), was created. Such registry should demonstrate comparability with population-based data to ensure representativeness at population level. The aim is to compare the socio-demographic characteristics of the TTR with incidence data from the Red de Registros de Cáncer (REDECAN) and mortality data from the Instituto Nacional de Estadística (INE). Method: Lung cancer data sources available to date, REDECAN and INE, were used. Lung cancer cases overall and disaggregated by sex and age groups were collected from each source of information and data were compared for the period 2017-2020. Sex and age group proportions of TTR were calculated for both databases (which collect incidence and mortality data), for the entire study period and broken down by year. Results: A total of 17,109 incident lung cancer cases from the TTR, 58,668 estimated incident cases from REDECAN and 88,083 deaths registered from INE between 2017 and 2020 were included. In terms of sex, the proportions are very similar between the three sources and the differences do not exceed 4%. In terms of age, the differences are not large, being larger for mortality data in the older age group from the INE versus the TTR. Conclusions: The TTR seems to be representative of lung cancer cases diagnosed in Spain between 2019 and 2020, both by sex and age. This allows us to accurately characterise the status of this disease, which is the leading cause of cancer death in Spain, and that the analysis of results obtained from the RTT can be applied to cases of lung cancer diagnosed in our country.

Published
2022
Full Text
View/download PDF

2. Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study

Author

Manuel Cobo, R. López-Castro, Amparo Sanchez-Gastaldo, Alberto Ruano-Ravina, Ana Laura Ortega, Bartomeu Massuti, Anna Estival, Oscar Juan, Enric Carcereny, Gretel Benítez, Mariano Provencio, Diego Pereiro Corbacho, Juana Oramas, Ana Blasco, Joaquín Mosquera-Martínez, Marta Belver, Carlos Guirao-Rubio, María Guirado-Risueño, Joaquim Bosch-Barrera, Edel del Barco Morillo, Jose Manuel Trigo, Delvys Rodriguez-Abreu, Manuel Domine, Carlos Aguado De La Rosa, Virginia Calvo de Juan, [Ruano-Ravina,A] Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain. [Ruano-Ravina,A] Consortium for Biomedical Research in Epidemiology & Public Health (CIBER en Epidemiología and Salud Pública/CIBERESP), Madrid, Spain. [Ruano-Ravina,A] Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela - IDIS), Santiago de Compostela, Spain. [Provencio,M, Calvo de Juan,V] Department of Oncology, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain. [Carcereny,E, Estival,A] Medical Oncology Department, Catalan Institute of Oncology, Badalona- Germans Trias i Pujol Hospital B-ARGO group, Barcelona, Spain. [Rodríguez-Abreu,D, Benítez,G] Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain. [López-Castro,R, Belver,M] Servicio de Oncología, Sección de oncología médica, Hospital Clínico Universitario de Valladolid, Valladolid, Spain. [Guirado-Risueño,M, Guirao-Rubio,C] Hospital de Elche, Elche, Spain, [Blasco,A] Hospital General de Valencia, Valencia, Spain. [Massutí,B] Hospital Universitario General de Alicante, Alicante, Spain. [Ortega,AL] Servicio de Oncología Médica. Complejo Hospitalario de Jaén, Jaén, Spain. [Cobo,M] Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain. [Mosquera-Martínez,J] Hospital Universitario de A Coruña, A Coruña, Spain. [Aguado de la Rosa,C] Department of Oncology, Clínico San Carlos Hospital, Madrid, Spain. [Bosch-Barrera,J] Girona Biomedical Research Institute (IDIBGI), Girona, Spain. [Bosch-Barrera,J] Department of Medical Sciences, Medical School, University of Girona, Girona, Spain. [Bosch-Barrera,J] Medical Oncology, Catalan Institute of Oncology, Hospital Universitari Dr. Josep Trueta, Girona, Catalonia, Spain. [Sánchez-Gastaldo,A] Department of Oncology, Hospital Virgen del Rocío, Seville, Spain. [del Barco Morillo,E] Department of Oncology, Hospital de Salamanca, Slamanca, Spain. [Juan,Ó] Servicio Oncología Médica, Hospital Universitari i Politécnic La Fe, Valencia, Spain. [Dómine,M] Hospital Jiménez Díaz, Madrid, Spain. [Trigo,JM] Servicio de Oncología Médica y Unidad de Fases I, Hospital Universitario Virgen de la Victoria, Málaga, Spain. [Pereiro Corbacho,D] Hospital Universitario Álvaro Cunqueiro, Vigo, Spain. [Oramas,J] Hospital Universitario de Canarias, Santa Cruz Tenerife, Spain., Institut Català de la Salut, [Ruano-Ravina A] Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain. Consortium for Biomedical Research in Epidemiology & Public Health (CIBER en Epidemiología and Salud Pública/CIBERESP), Madrid, Spain. Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela - IDIS), Santiago de Compostela, Spain. [Provencio M, Calvo de Juan V] Department of Oncology, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain. [Carcereny E, Estival A] Medical Oncology Department, Catalan Institute of Oncology, Badalona- Germans Trias i Pujol Hospital B-ARGO group, Barcelona, Spain. [Rodríguez-Abreu D, Benítez G] Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain. [López Castro R, Belver M] Servicio de Oncología, Sección de oncología médica, Hospital Clínico Universitario de Valladolid, Valladolid, Spain. [Guirado Risueño M, Guirao-Rubio C] Hospital de Elche, Elche, Spain.[ Blasco A] Hospital General de Valencia, Valencia, Spain. [Massutí B] Hospital Universitario General de Alicante, Alicante, Spain. [Ortega Granados AL] Servicio de Oncología Médica. Complejo Hospitalario de Jaén, Jaén, Spain. [Cobo M] Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain.[ Mosquera-Martínez J] Hospital Universitario de A Coruña, A Coruña, Spain. [Aguado C] Department of Oncology, Clínico San Carlos Hospital, Madrid, Spain. [Bosch-Barrera J] Girona Biomedical Research Institute (IDIBGI), Girona, Spain. Department of Medical Sciences, Medical School, University of Girona, Girona, Spain. Medical Oncology, Catalan Institute of Oncology, Hospital Universitari de Girona Doctor Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. [Sanchez Gastaldo A] Department of Oncology, Hospital Virgen del Rocío, Seville, Spain. [Del Barco Morillo E] Department of Oncology, Hospital de Salamanca, Salamanca, Spain. [Juan O] Servicio Oncología Médica, Hospital Universitari i Politécnic La Fe, Valencia, Spain. [Dómine M] Hospital Jiménez Díaz, Madrid, Spain. [Trigo J] Servicio de Oncología Médica y Unidad de Fases I, Hospital Universitario Virgen de la Victoria, Málaga, Spain. [Pereiro Corbacho D] Hospital Universitario Álvaro Cunqueiro, Vigo, Spain. [Oramas J] Hospital Universitario de Canarias, Santa Cruz Tenerife, Spain, and Hospital Universitari de Girona Dr Josep Trueta

Subjects
Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Signs and Symptoms, Digestive::Anorexia [Medical Subject Headings], Carcinoma pulmonar de células pequeñas, Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Tobacco Use::Smoking [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors [Medical Subject Headings], Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Pulmons - Càncer, Weight loss, Lung neoplasms, Other subheadings::/diagnosis [Other subheadings], Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Adenocarcinoma [Medical Subject Headings], Fumar, Fumadors, Stage (cooking), conducta y mecanismos de la conducta::conducta::fumar [PSIQUIATRÍA Y PSICOLOGÍA], Diseases::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [Medical Subject Headings], Smoking, Small cell lung cancer (SCLC), Disciplines and Occupations::Natural Science Disciplines::Physics::Electronics [Medical Subject Headings], Anorexia, Oncology, Adenocarcinoma, Smoking status, Original Article, Sex, medicine.symptom, Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Asthenia [Medical Subject Headings], Behavior and Behavior Mechanisms::Behavior::Smoking [PSYCHIATRY AND PSYCHOLOGY], medicine.medical_specialty, Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms [DISEASES], Neoplasias pulmonares, Otros calificadores::/diagnóstico [Otros calificadores], Check Tags::Male [Medical Subject Headings], Sexo, Diseases::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms [Medical Subject Headings], enfermedades respiratorias::enfermedades respiratorias::neoplasias del tracto respiratorio::neoplasias pulmonares [ENFERMEDADES], Internal medicine, medicine, Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Body Weight::Body Weight Changes::Weight Loss [Medical Subject Headings], Lung cancer, business.industry, Anthropology, Education, Sociology and Social Phenomena::Social Sciences::Demography [Medical Subject Headings], Cancer, medicine.disease, Astenia, Health Care Quality, Access, and Evaluation::Quality of Health Care::Epidemiologic Factors::Sex Factors [HEALTH CARE], Check Tags::Female [Medical Subject Headings], Asthenia, Diferències entre sexes, Symptoms, calidad, acceso y evaluación de la atención sanitaria::calidad de la atención sanitaria::factores epidemiológicos::factores sexuales [ATENCIÓN DE SALUD], Síntomas, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Registries [Medical Subject Headings], Stage iv, business
Abstract

Càncer de pulmó; Fumar; Diferències entre sexes Cancer de pulmón; Fumar; Diferencias entre sexos Lung neoplasms; Smoking; Sex Factors Background: Lung cancer causes approximately 25% of all cancer deaths. Despite its relevance, few studies have analyzed differences by sex at the time of diagnosis in terms of symptoms, stage, age or smoking status. We aim to assess if there are differences between men and women on these characteristics at diagnosis. Methods: We analyzed the Thoracic Tumour Registry (TTR), sponsored by the Spanish Lung Cancer Group using a case-series design. This is a nationwide registry of lung cancer cases which started recruitment in 2016. For each case included, clinicians fulfilled an electronic record registering demographic data, symptoms, exposure to lung cancer risk factors, and treatment received in detail. We compared men and women using descriptive statistics. Results: A total of 13,590 participants took part in this study, 25.6% women. Women were 4 years younger than men (64 vs. 69), and men had smoked more frequently. Adenocarcinoma was the most frequent histological type in both sexes. Stage IV at diagnosis was 50.8% in women compared to 43.6% in men. Weight loss/anorexia/asthenia was the most frequent symptom in both sexes and there were no differences in the number of symptoms at diagnosis. There were no relevant differences in the frequency or number of symptoms by sex when non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC) were analyzed separately. Smoking status did not appear to cause different lung cancer presentation in men compared to women. Conclusions: There seems to be no differences in lung cancer characteristics by sex at the time at diagnosis on stage, specific symptoms or number of symptoms. This research received funding from the Spanish Lung Cancer Group

Published
2021

3. First analysis of the National Lung Cancer Register in Spain (RTT)

Author

Pilar Lianes, Manuel Domine, María Ángeles Sala, Miguel A. Muñoz, Carlos Camps, Miriam Dorta, Mariano Provencio-Pulla, Elvira Del Barco Morillo, Esther Noguerón, Bartomeu Massuti, Remei Blanco, Rosario Garcia Campelo, Julia Calzas, Ramon De Las Penas, Jose-Luis Gonzalez-Larriba, Delvys Rodriguez Abreu, J. Casal, Enric Carcereny, Joaquim Bosch, and María Guirado-Risueño

Subjects
congenital, hereditary, and neonatal diseases and abnormalities, Cancer Research, medicine.medical_specialty, integumentary system, Oncology, Register (music), business.industry, Internal medicine, medicine, Lung cancer, medicine.disease, business
Abstract

e13608Background: The Spanish Lung Cancer Group (GECP) initiated a Tumor Thoracic Register (RTT) in September 2016 with the aim of evaluating accurate, basic data concerning this oncological pathol...

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results